Anadys To Be Bought by Roche for $230M

by Web Master, Benzinga Editor

October 17, 2011 6:08 AM | 3 seconds read | Make a Comment

Anadys Pharmaceuticals agrees to be bought for $230 million by Roche.

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.